Discovery of an NRAS isoform and activation-state selective macrocyclic peptide
Kenneth K. Hallenbeck, Yunpeng Zhou, Hubert Josien, Songnian Lin et autres
0 citationsbioRxiv (Cold Spring Harbor Laboratory)
My Sam Mansueto
Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.
75Publications signalées
484Citations signalées
2Affiliations récentes
Institutions déclarées
Domaines associés
Hippo pathway signaling and YAP/TAZMelanoma and MAPK PathwaysLiver physiology and pathologyMonoclonal and Polyclonal Antibodies ResearchComputational Drug Discovery Methods
Publications récentes
Supplementary table 2 from Activation of Hepatocyte Growth Factor/MET Signaling as a Mechanism of Acquired Resistance to a Novel YAP1/TEAD Small Molecule Inhibitor
Casey J. Moure, Brandon Vara, Mangeng Cheng, Christopher Sondey et autres
0 citations
Figure S6 from Activation of Hepatocyte Growth Factor/MET Signaling as a Mechanism of Acquired Resistance to a Novel YAP1/TEAD Small Molecule Inhibitor
Casey J. Moure, Brandon Vara, Mangeng Cheng, Christopher Sondey et autres
0 citations
Figure S3 from Activation of Hepatocyte Growth Factor/MET Signaling as a Mechanism of Acquired Resistance to a Novel YAP1/TEAD Small Molecule Inhibitor
Casey J. Moure, Brandon Vara, Mangeng Cheng, Christopher Sondey et autres
0 citations
Figure S2 from Activation of Hepatocyte Growth Factor/MET Signaling as a Mechanism of Acquired Resistance to a Novel YAP1/TEAD Small Molecule Inhibitor
Casey J. Moure, Brandon Vara, Mangeng Cheng, Christopher Sondey et autres
0 citations
Supplementary table 1 from Activation of Hepatocyte Growth Factor/MET Signaling as a Mechanism of Acquired Resistance to a Novel YAP1/TEAD Small Molecule Inhibitor
Casey J. Moure, Brandon Vara, Mangeng Cheng, Christopher Sondey et autres
0 citations
Figure S1 from Activation of Hepatocyte Growth Factor/MET Signaling as a Mechanism of Acquired Resistance to a Novel YAP1/TEAD Small Molecule Inhibitor
Casey J. Moure, Brandon Vara, Mangeng Cheng, Christopher Sondey et autres
0 citations
Figure S5 from Activation of Hepatocyte Growth Factor/MET Signaling as a Mechanism of Acquired Resistance to a Novel YAP1/TEAD Small Molecule Inhibitor
Casey J. Moure, Brandon Vara, Mangeng Cheng, Christopher Sondey et autres
0 citations
Figure S4 from Activation of Hepatocyte Growth Factor/MET Signaling as a Mechanism of Acquired Resistance to a Novel YAP1/TEAD Small Molecule Inhibitor
Casey J. Moure, Brandon Vara, Mangeng Cheng, Christopher Sondey et autres
0 citations
Discovery of Potent and Selective Benzothiophene Difluoromethyl Phosphonate (DFMP) PTPN2/N1-Dual Inhibitors
Xiao Mei Zheng, David A. Candito, James Jewell, Matthew Childers et autres
0 citationsJournal of Medicinal Chemistry
From KRAS G12D to Pan-KRAS Inhibitors─A Journey Enabled by Synthetic Innovation and Structure-Based Drug Design
Xiaoshen Ma, David L. Sloman, Timothy J. Henderson, David Jonathan Bennett et autres
1 citationJournal of Medicinal Chemistry
Discovery and In Vivo Evaluation of Aryl Ether YAP1/TEAD Inhibitors for the Treatment of Hippo-Driven Malignancies
Brandon Vara, Jongwon Lim, Casey J. Moure, Sebastian E. Schneider et autres
2 citationsJournal of Medicinal Chemistry
BNTIC News n’est pas le producteur de ces données. Recherche à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, ROR et la Banque mondiale, sans clé ; OpenAlex reste optionnel. Aucun service payant requis, aucune donnée externe enregistrée en base. Sources et limites.